UPDATE : Saturday, February 22, 2020
Bridge Biotherapeutics seeks IND status for lung cancer treatment by Lee Han-soo 2019-12-20 14:41
Boehringer Ingelheim stops developing Pharmaxis’ NASH treatment candidate by Lee Han-soo 2019-12-19 17:42
AstraZeneca, Korean partners launch joint project to accelerate bio-health innovation by Lee Han-soo 2019-12-19 17:40
AstraZeneca, SK Holdings celebrates manufacturing partnership by Lee Han-soo 2019-12-19 16:39
SNUBH uses heart rate to predict beta-blocker effect by Lee Han-soo 2019-12-19 14:41
Macrogen, Thermo Fisher Scientific tie up to expand capillary electrophoresis sequencing service by Lee Han-soo 2019-12-19 14:19
[Column] Navigating a changing healthcare landscape with focus on patient centricity by Peter Soelkner 2019-12-19 12:10
Daewoong wins sales approval for Nabota in UAE, Indonesia by Lee Han-soo 2019-12-19 12:09
Crystal Genomics acquires Hwail as subsidiary by Lee Han-soo 2019-12-18 17:48
Psomagen-Macrogen consortium acquires uBiome's patents, data by Lee Han-soo 2019-12-18 16:56
‘Digital mammography for breast cancer screening most accurate’ by Lee Han-soo 2019-12-18 15:28
‘Prevalence of familial prostate cancer similar to Western countries’ by Lee Han-soo 2019-12-18 14:39
Regulatory agency expands cooperation with European counterparts by Lee Han-soo 2019-12-18 11:22
'Patients with anemia more likely to have dementia' by Lee Han-soo 2019-12-17 18:05
Healcerion set to supply portable ultrasound device to US military by Lee Han-soo 2019-12-17 16:40
‘Roche's Xofluza to revolutionize influenza antivirals’ by Lee Han-soo 2019-12-17 16:30
Novartis reaffirms efficacy of Tasigna in treating chronic myelogenous leukemia by Lee Han-soo 2019-12-17 14:48
CJ Healthcare unites with Standigm to develop AI-based anticancer drugs by Lee Han-soo 2019-12-17 11:58
Celltrion secures 11 generic drugs to advance to US market by Lee Han-soo 2019-12-16 17:02
Dong-A, Meiji Seika to conduct P1 trial for Stelara biosimilar by Lee Han-soo 2019-12-16 17:01
Back to Top